This inventor holds 1 USPTO granted patent. Top assignees: Ewha University-Industry Collaboration Foundation, Seoul National University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 206 
1 out of 1,789 
Years Active: 2024
Title: Dobeen Hwang: Innovator in Ocular Therapeutics
Introduction
Dobeen Hwang is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of ocular therapeutics, particularly through his innovative research and development of antibodies.
Latest Patents
Dobeen Hwang holds a patent for a PDGF receptor antibody and its use in treating ocular neovascular diseases. This invention involves an antibody against the PDGF receptor, which is conjugated with a chemotherapeutic agent to enhance treatment efficacy.
Career Highlights
Throughout his career, Dobeen Hwang has worked with prestigious institutions, including Seoul National University and the Ewha University-Industry Collaboration Foundation. His work has focused on advancing medical treatments and improving patient outcomes in ocular health.
Collaborations
Dobeen has collaborated with talented individuals such as Soohyun Kim and Hyori Kim, contributing to the advancement of research in his field.
Conclusion
Dobeen Hwang's innovative work in developing therapeutic antibodies showcases his commitment to improving healthcare solutions for ocular diseases. His contributions are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile